{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:49:48Z","timestamp":1792633788495,"version":"4.5.0"},"reference-count":83,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"am","delay-in-days":370,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100002567","name":"American Academy of Allergy Asthma and Immunology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002567","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"NCATS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jaci-inpractice.org","clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.jaip.2024.07.028","type":"journal-article","created":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T03:00:38Z","timestamp":1722913238000},"page":"3025-3033.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["A Skin Testing Strategy for Non\u2013IgE-Mediated Reactions Associated With Vancomycin"],"prefix":"10.1016","volume":"12","author":[{"given":"Siyan","family":"Lyu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric T.","family":"Oliver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie C.","family":"Dispenza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin L.","family":"Chichester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald W.","family":"MacGlashan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. Franklin","family":"Adkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth J.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4110-7221","authenticated-orcid":false,"given":"Santiago","family":"Alvarez-Arango","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2024.07.028_bib1","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-29965-8","article-title":"MRGPRX2-mediated mast cell response to drugs used in perioperative procedures and anaesthesia","volume":"8","author":"Navin\u00e9s-Ferrer","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaip.2024.07.028_bib2","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jaip.2022.11.001","article-title":"Patient characteristics associated with reactions to Mrgprx2-activating drugs in an electronic health record\u2013linked biobank","volume":"11","author":"Foer","year":"2023","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.07.028_bib3","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1056\/NEJMp2031891","article-title":"Vancomycin infusion reaction\u2014moving beyond \u201cred man syndrome\u201d","volume":"384","author":"Alvarez-Arango","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2024.07.028_bib4","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.jaip.2020.09.027","article-title":"Vancomycin hypersensitivity reactions documented in electronic health records","volume":"9","author":"Alvarez-Arango","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.07.028_bib5","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1097\/itx.0000000000000005","article-title":"MRGPRX2, atopic dermatitis, and red man syndrome","volume":"2","author":"Azimi","year":"2017","journal-title":"Itch"},{"key":"10.1016\/j.jaip.2024.07.028_bib6","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.547","article-title":"MrgX2 is a promiscuous receptor for basic peptides causing mast cell pseudo-allergic and anaphylactoid reactions","volume":"7","author":"Grimes","year":"2019","journal-title":"Pharmacol Res Perspect"},{"key":"10.1016\/j.jaip.2024.07.028_bib7","first-page":"402","article-title":"Vancomycin anaphylaxis and successful desensitization","volume":"73","author":"Anne","year":"1994","journal-title":"Ann Allergy"},{"key":"10.1016\/j.jaip.2024.07.028_bib8","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S1081-1206(10)62416-7","article-title":"Vancomycin anaphylaxis and successful desensitization in a patient with end stage renal disease on hemodialysis by maintaining steady antibiotic levels","volume":"84","author":"Chopra","year":"2000","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2024.07.028_bib9","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/00045391-200007050-00010","article-title":"Vancomycin anaphylaxis in a patient with vancomycin-induced red man syndrome","volume":"7","author":"Hassaballa","year":"2000","journal-title":"Am J Therapeut"},{"key":"10.1016\/j.jaip.2024.07.028_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2015.12.145","article-title":"Immune-mediated reactions to vancomycin: a systematic review","volume":"137","author":"Minhas","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.07.028_bib11","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1345\/aph.1A002","article-title":"Desensitization protocols for vancomycin hypersensitivity","volume":"35","author":"Wazny","year":"2001","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jaip.2024.07.028_bib12","first-page":"60","article-title":"Allergic reaction or adverse drug effect: correctly classifying vancomycin-induced hypersensitivity reactions","volume":"38","author":"McAuley","year":"2012","journal-title":"J\u00a0Emerg Nurs"},{"key":"10.1016\/j.jaip.2024.07.028_bib13","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/all.13848","article-title":"The challenge of de-labeling penicillin allergy","volume":"75","author":"Stone","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.07.028_bib14","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1111\/all.12881","article-title":"Drug allergies documented in electronic health records of a large healthcare system","volume":"71","author":"Zhou","year":"2016","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.07.028_bib15","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.3390\/antibiotics11111543","article-title":"Meta-analysis of clinical trials comparing cefazolin to cefuroxime, ceftriaxone, and cefamandole for surgical site infection prevention","volume":"11","author":"Ahmed","year":"2022","journal-title":"Antibiotics"},{"key":"10.1016\/j.jaip.2024.07.028_bib16","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/all.12350","article-title":"International Consensus on drug allergy","volume":"69","author":"Demoly","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.07.028_bib17","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.anai.2017.11.022","article-title":"Clinical and economic burden of hospitalizations with registration of penicillin allergy","volume":"120","author":"Sousa-Pinto","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2024.07.028_bib18","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.jaip.2024.02.019","article-title":"Non-IgE-mediated immediate drug-induced hypersensitivity reactions","volume":"12","author":"Alvarez-Arango","year":"2024","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.07.028_bib19","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/INF.0b013e31824e10d7","article-title":"Defining risk factors for red man syndrome in children and adults","volume":"31","author":"Myers","year":"2012","journal-title":"Pediatr infect Dis J"},{"key":"10.1016\/j.jaip.2024.07.028_bib20","first-page":"1","article-title":"Red man syndrome","volume":"7","author":"Sivagnanam","year":"2002","journal-title":"Crit Care"},{"key":"10.1016\/j.jaip.2024.07.028_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1026304","article-title":"Mas-related G protein-coupled receptor MRGPRX2 in human basophils: expression and functional studies","volume":"13","author":"Toscano","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2024.07.028_bib22","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.3390\/cells10051033","article-title":"Unlocking the non-IgE-mediated pseudo-allergic reaction puzzle with mas-related G-protein coupled receptor member X2 (MRGPRX2)","volume":"10","author":"Kumar","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.jaip.2024.07.028_bib23","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1111\/all.14213","article-title":"The pseudoallergen receptor MRGPRX2 on peripheral blood basophils and eosinophils: expression and function","volume":"75","author":"Wedi","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.07.028_bib24","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jdermsci.2016.05.006","article-title":"Angiogenic peptide (AG)-30\/5C activates human keratinocytes to produce cytokines\/chemokines and to migrate and proliferate via MrgX receptors","volume":"83","author":"Kiatsurayanon","year":"2016","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.jaip.2024.07.028_bib25","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3389\/fncel.2019.00299","article-title":"Heterogeneity of human mast cells with respect to MRGPRX2 receptor expression and function","volume":"13","author":"Varricchi","year":"2019","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.jaip.2024.07.028_bib26","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.tips.2023.02.002","article-title":"The structure, function, and pharmacology of MRGPRs","volume":"44","author":"Cao","year":"2023","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.jaip.2024.07.028_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.676354","article-title":"MRGPRX2 and adverse drug reactions","volume":"12","author":"McNeil","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2024.07.028_bib28","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jaip.2022.12.014","article-title":"Allergenic and mas-related G protein-coupled receptor X2-activating properties of drugs: resolving the two","volume":"11","author":"Sabato","year":"2023","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.07.028_bib29","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.3389\/fimmu.2018.03027","article-title":"Mas-related G protein-coupled receptor-X2 (MRGPRX2) in drug hypersensitivity reactions","volume":"9","author":"Porebski","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2024.07.028_bib30","doi-asserted-by":"crossref","first-page":"3981","DOI":"10.1172\/JCI85538","article-title":"Different activation signals induce distinct mast cell degranulation strategies","volume":"126","author":"Gaudenzio","year":"2016","journal-title":"J\u00a0Clin Investig"},{"key":"10.1016\/j.jaip.2024.07.028_bib31","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.jaci.2022.09.004","article-title":"MRGPRX2 in drug allergy: what we know and what we do not know","volume":"151","author":"Kolkhir","year":"2023","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.07.028_bib32","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1128\/AAC.36.6.1204","article-title":"Absence of \u201cred man syndrome\u201d in patients being treated with vancomycin or high-dose teicoplanin","volume":"36","author":"Rybak","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jaip.2024.07.028_bib33","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.jaci.2022.08.028","article-title":"Drug allergy: a 2022 Practice Parameter Update","volume":"150","author":"Khan","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.07.028_bib34","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/all.12142","article-title":"Skin test concentrations for systemically administered drugs\u2013an ENDA\/EAACI Drug Allergy Interest Group position paper","volume":"68","author":"Brockow","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.07.028_bib35","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-2222.2008.03155.x","article-title":"BSACI guidelines for the management of drug allergy","volume":"39","author":"Mirakian","year":"2009","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2024.07.028_bib36","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1111\/cea.13850","article-title":"Vancomycin immediate skin responses in vancomycin-na\u00efve subjects","volume":"51","author":"Alvarez-Arango","year":"2021","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2024.07.028_bib37","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.jaip.2020.09.017","article-title":"Criteria for intradermal skin testing and oral challenge in patients labeled as fluoroquinolone allergic","volume":"9","author":"Krantz","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.07.028_bib38","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jaci.2018.09.022","article-title":"Controversies in drug allergy: in\u00a0vitro testing","volume":"143","author":"Mayorga","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.07.028_bib39","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1111\/all.14252","article-title":"Surface expression of MRGPRX2 on resting basophils: an area of controversy","volume":"75","author":"Sabato","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.07.028_bib40","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jaci.2004.04.029","article-title":"Clinical features and severity grading of anaphylaxis","volume":"114","author":"Brown","year":"2004","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.07.028_bib41","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.jaci.2023.08.018","article-title":"United States Drug Allergy Registry (USDAR) grading scale for immediate drug reactions","volume":"152","author":"Khan","year":"2023","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.07.028_bib42","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jaci.2013.06.038","article-title":"Basophil activation testing","volume":"132","author":"MacGlashan","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.07.028_bib43","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1111\/j.1365-2222.2010.03572.x","article-title":"Expression of CD203c and CD63 in human basophils: relationship to differential regulation of piecemeal and anaphylactic degranulation processes","volume":"40","author":"MacGlashan","year":"2010","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2024.07.028_bib44","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000490152","article-title":"Dependence of optimal histamine release on cell surface IgE density on human basophils: nature of the stimulus","volume":"177","author":"Nejad","year":"2018","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2024.07.028_bib45","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0022-1759(87)90419-4","article-title":"A\u00a0rapid Percoll technique for the purification of human basophils","volume":"105","author":"Warner","year":"1987","journal-title":"J\u00a0Immunol Methods"},{"key":"10.1016\/j.jaip.2024.07.028_bib46","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0003-2697(74)90093-1","article-title":"An automated continuous-flow system for the extraction and fluorometric analysis of histamine","volume":"57","author":"Siraganian","year":"1974","journal-title":"Analytical Biochem"},{"key":"10.1016\/j.jaip.2024.07.028_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0126435","article-title":"Expression profiling of human basophils: modulation by cytokines and secretagogues","volume":"10","author":"MacGlashan","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jaip.2024.07.028_bib48","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1182\/blood-2008-05-157818","article-title":"Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33","volume":"113","author":"Pecaric-Petkovic","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2024.07.028_bib49","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1128\/AAC.37.10.2139","article-title":"Vancomycin skin tests and prediction of \u201cred man syndrome\u201d in healthy volunteers","volume":"37","author":"Polk","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jaip.2024.07.028_bib50","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jaci.2014.05.004","article-title":"Expression of Mas-related gene X2 on mast cells is upregulated in the skin of patients with severe chronic urticaria","volume":"134","author":"Fujisawa","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.07.028_bib51","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.jid.2020.06.030","article-title":"MRGPRX2 activation causes increased skin reactivity in patients with chronic spontaneous urticaria","volume":"141","author":"Shtessel","year":"2021","journal-title":"J\u00a0Investig Dermatol"},{"key":"10.1016\/j.jaip.2024.07.028_bib52","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.gene.2005.03.001","article-title":"Adaptive evolution of MRGX2, a human sensory neuron specific gene involved in nociception","volume":"352","author":"Yang","year":"2005","journal-title":"Gene"},{"key":"10.1016\/j.jaip.2024.07.028_bib53","doi-asserted-by":"crossref","first-page":"343","DOI":"10.4049\/jimmunol.1701793","article-title":"Naturally occurring missense MRGPRX2 variants display loss of function phenotype for mast cell degranulation in response to substance P, hemokinin-1, human \u03b2-defensin-3, and icatibant","volume":"201","author":"Alkanfari","year":"2018","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaip.2024.07.028_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.688930","article-title":"Antibody or anybody? Considering the role of MRGPRX2 in acute drug-induced anaphylaxis and as a therapeutic target","volume":"12","author":"Mackay","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2024.07.028_bib55","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1111\/bcp.15845","article-title":"MRGPRX2, drug pseudoallergies, inflammatory diseases, mechanisms, and distinguishing MRGPRX2-and IgE\/Fc\u03b5RI-mediated events","volume":"89","author":"Baldo","year":"2023","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jaip.2024.07.028_bib56","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1111\/all.13236","article-title":"Immediate moxifloxacin hypersensitivity: is there more than currently meets the eye?","volume":"72","author":"Van Gasse","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.07.028_bib57","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.bja.2023.05.002","article-title":"Suspected perioperative anaphylaxis: are we making the correct diagnosis?","volume":"131","author":"Ebo","year":"2023","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jaip.2024.07.028_bib58","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.anai.2016.10.003","article-title":"Skin testing and drug challenge outcomes in antibiotic-allergic patients with immediate-type hypersensitivity","volume":"118","author":"Mawhirt","year":"2017","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2024.07.028_bib59","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1016\/j.jaip.2023.06.031","article-title":"Endotyping of IgE-mediated polyethylene glycol and\/or polysorbate 80 allergy","volume":"11","author":"Ieven","year":"2023","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.07.028_bib60","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1111\/all.14834","article-title":"Nanoarchitectures for efficient IgE cross-linking on effector cells to study amoxicillin allergy","volume":"76","author":"Tesfaye","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.07.028_bib61","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/0091-6749(90)90046-7","article-title":"A\u00a0comparative study of releasing and nonreleasing human basophils: nonreleasing basophils lack an early component of the signal transduction pathway that follows IgE cross-linking","volume":"85","author":"Nguyen","year":"1990","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.07.028_bib62","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1111\/all.14747","article-title":"Basophil activation test: mechanisms and considerations for use in clinical trials and clinical practice","volume":"76","author":"Santos","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.07.028_bib63","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1398-9995.2010.02460.x","article-title":"In\u00a0vitro evaluation of IgE-mediated hypersensitivity reactions to quinolones","volume":"66","author":"Aranda","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.07.028_bib64","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1111\/j.1398-9995.2006.01094.x","article-title":"Flow-assisted diagnostic management of anaphylaxis from rocuronium bromide","volume":"61","author":"Ebo","year":"2006","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.07.028_bib65","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/cyto.b.21074","article-title":"IgE-mediated allergy to pholcodine and cross-reactivity to neuromuscular blocking agents: lessons from flow cytometry","volume":"84","author":"Leysen","year":"2013","journal-title":"Cytometry B Clin Cytom"},{"key":"10.1016\/j.jaip.2024.07.028_bib66","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1111\/all.12468","article-title":"Flowcytometric diagnosis of atracurium-induced anaphylaxis","volume":"69","author":"Uyttebroek","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.07.028_bib67","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jaip.2014.12.002","article-title":"IgE to poppy seed and morphine are not useful tools to diagnose opiate allergy","volume":"3","author":"Van Gasse","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.07.028_bib68","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.bja.2018.02.033","article-title":"Outcome of repeat anaesthesia after investigation for perioperative anaphylaxis","volume":"120","author":"Miller","year":"2018","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jaip.2024.07.028_bib69","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.annfar.2004.10.013","volume":"23","year":"2004","journal-title":"Ann Fr Anesth Reanim"},{"key":"10.1016\/j.jaip.2024.07.028_bibE1","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3389\/fmed.2020.00156","article-title":"Intradermal tests with drugs: an approach to standardization","volume":"7","author":"Barbaud","year":"2020","journal-title":"Front Med"},{"key":"10.1016\/j.jaip.2024.07.028_bibE2","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1111\/cea.13850","article-title":"Vancomycin immediate skin responses in vancomycin-na\u00efve subjects","volume":"51","author":"Alvarez-Arango","year":"2021","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2024.07.028_bibE3","doi-asserted-by":"crossref","first-page":"8196","DOI":"10.1016\/j.bmc.2008.07.035","article-title":"Antibacterial profile against drug-resistant Staphylococcus epidermidis clinical strain and structure\u2013activity relationship studies of 1H-pyrazolo [3, 4-b] pyridine and thieno [2, 3-b] pyridine derivatives","volume":"16","author":"Leal","year":"2008","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.jaip.2024.07.028_bibE4","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-29965-8","article-title":"MRGPRX2-mediated mast cell response to drugs used in perioperative procedures and anaesthesia","volume":"8","author":"Navin\u00e9s-Ferrer","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaip.2024.07.028_bibE5","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1097\/itx.0000000000000005","article-title":"MRGPRX2, atopic dermatitis, and red man syndrome","volume":"2","author":"Azimi","year":"2017","journal-title":"Itch"},{"key":"10.1016\/j.jaip.2024.07.028_bibE6","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.547","article-title":"MrgX2 is a promiscuous receptor for basic peptides causing mast cell pseudo-allergic and anaphylactoid reactions","volume":"7","author":"Grimes","year":"2019","journal-title":"Pharmacol Res Perspect"},{"key":"10.1016\/j.jaip.2024.07.028_bibE7","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ejphar.2011.06.027","article-title":"G protein coupled receptor specificity for C3a and compound 48\/80-induced degranulation in human mast cells: roles of Mas-related genes MrgX1 and MrgX2","volume":"668","author":"Kashem","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jaip.2024.07.028_bibE8","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/bs.ai.2017.06.002","article-title":"Emerging roles for MAS-related G protein-coupled receptor-X2 in host defense peptide, opioid, and neuropeptide-mediated inflammatory reactions","volume":"136","author":"Ali","year":"2017","journal-title":"Adv Immunol"},{"key":"10.1016\/j.jaip.2024.07.028_bibE9","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature14022","article-title":"Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions","volume":"519","author":"McNeil","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jaip.2024.07.028_bibE10","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000490152","article-title":"Dependence of optimal histamine release on cell surface IgE density on human basophils: nature of the stimulus","volume":"177","author":"Nejad","year":"2018","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2024.07.028_bibE11","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0022-1759(87)90419-4","article-title":"A\u00a0rapid Percoll technique for the purification of human basophils","volume":"105","author":"Warner","year":"1987","journal-title":"J\u00a0Immunol Methods"},{"key":"10.1016\/j.jaip.2024.07.028_bibE12","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0003-2697(74)90093-1","article-title":"An automated continuous-flow system for the extraction and fluorometric analysis of histamine","volume":"57","author":"Siraganian","year":"1974","journal-title":"Analytical Biochem"},{"key":"10.1016\/j.jaip.2024.07.028_bibE13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0126435","article-title":"Expression profiling of human basophils: modulation by cytokines and secretagogues","volume":"10","author":"MacGlashan","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jaip.2024.07.028_bibE14","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1182\/blood-2008-05-157818","article-title":"Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33","volume":"113","author":"Pecaric-Petkovic","year":"2009","journal-title":"Blood"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219824007785?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219824007785?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T15:40:18Z","timestamp":1732117218000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219824007785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":83,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S2213219824007785"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2024.07.028","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Skin Testing Strategy for Non\u2013IgE-Mediated Reactions Associated With Vancomycin","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2024.07.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}